The Federal Drug Administration’s current cybersecurity requirements are not appropriate for addressing and avoiding medical ...
The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
Venezuelan President Nicolas Maduro pleaded not guilty to all four charges against him on Monday. His wife, Cilia Flores, ...
The S Club Juniors party came to an end in 2004 when Frankie Sandford, Rochelle Wiseman, Daisy Evans, Jay Asforis, Aaron ...
Atlanta rapper Cash Out, who was sentenced to spend the rest of his life in prison, has been ordered to pay $40 million to ...
The Daily Overview on MSN
Social Security COLA outlook just flipped, and seniors won't like it
After months of speculation that soaring prices might deliver another hefty boost to Social Security checks, the reality for ...
Travel Culture Life on MSN
What British expats say they can’t get used to about Canadian life
Moving to Canada seems like a dream come true for many British expats. The country offers stunning landscapes, friendly ...
Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...
Southwest General Health Center will host sessions on January 8 and February 12 where pharmacists will examine prescription combinations for potential risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback